Bromocriptine quick‐release as adjunct therapy in youth and adults with type 1 diabetes: A randomized, placebo‐controlled crossover study is a research paper published in Diabetes Obesity and Metabolism (2022). On theSindex it has a DataRank of 0.526. It has been cited 13 times, with 9 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.396
From this paper's citation signal
Citation Network Contribution
0.130
From 6 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 9 citers.
Juvenile Diabetes Research Foundation United States of America
Grant: 3‐SRA‐2015‐125‐M‐R
National Institutes of Health
Grant: TR001082
National Institutes of Health
Grant: UL1
NCATS NIH HHS
Grant: UL1 TR001082
NIDDK NIH HHS
Grant: P30 DK116073
NHLBI NIH HHS
Grant: K24 HL145076
National Institutes of Health
Grant: 5UL1TR001082-05
Colorado Clinical and Translational Sciences Institute
Pediatric Endocrine Society
American Diabetes Association
FWCI
1.25
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals